Every Cure’s drug repurposing strategy isn't what you think, and it could change rare disease treatment

TL;DR

watch now Every pause in the Iran war looks like 'selling time' for chip stocks: CIO Kingsley Jones, founding partner and CIO of Jevons Global, discusses how he's investing given the current geopolitical risks and volatility from the Iran war. 05:15 7 minutes ago There are over 10,000 rare diseases — 95% of which don't have a cure. It can cost billions of dollars and take more than a decade to develop a new treatment.